RoX Health is a digital health innovation studio within the Roche Group that combines startup agility with the scale and strategic depth of a global pharmaceutical and diagnostics company. Based in Berlin, Germany, RoX partners with startups, innovators and healthcare organisations to explore, test and validate new digital health business models through real-world pilots. Our mission is to translate fast experiments into scalable solutions that create meaningful impact for patients and healthcare systems.

RoX focuses on early- to growth-stage digital health ventures with strategic fit to Roche. We operate at the intersection of startups, healthcare systems and industry, enabling rapid real-world experimentation, regulatory and market-access support, portfolio development and pathways to commercialization. Core therapeutic and diagnostic focus areas include cardiovascular & metabolism (including obesity and heart failure), neurology (notably Alzheimer’s) and digital pathology.